{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:02:11Z","timestamp":1768698131311,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jiac.2022.03.017","type":"journal-article","created":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T19:11:51Z","timestamp":1648321911000},"page":"918-922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vancomycin MIC creep progresses in methicillin-resistant Staphylococcus aureus despite the national antimicrobial stewardship campaign: Single facility data in Japan"],"prefix":"10.1016","volume":"28","author":[{"given":"Takumi","family":"Fujimori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5086-1891","authenticated-orcid":false,"given":"Hideharu","family":"Hagiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Iio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Higashionna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Kakehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Okura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Minabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukika","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7014-9095","authenticated-orcid":false,"given":"Fumio","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Higashikage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2022.03.017_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.03.017_bib2","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/cid\/ciaa303","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American society of health-system pharmacists, the infectious diseases society of America, the pediatr","volume":"71","author":"Rybak","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.03.017_bib3","first-page":"269","article-title":"Focus: infectious diseases: vancomycin resistance in Staphylococcus aureus","volume":"90","author":"McGuinness","year":"2017","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.jiac.2022.03.017_bib4","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/jama.2016.11764","article-title":"Antimicrobial resistance","volume":"316","author":"Marston","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2022.03.017_bib5","doi-asserted-by":"crossref","first-page":"12689","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis","volume":"10","author":"Shariati","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2022.03.017_bib6","series-title":"Performance standards for antimicrobial susceptibility testing, M100","year":"2021"},{"key":"10.1016\/j.jiac.2022.03.017_bib7","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jiph.2020.07.008","article-title":"Occurrence of vancomycin MIC creep in methicillin resistant isolates in Saudi Arabia","volume":"13","author":"Aljohani","year":"2020","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jiac.2022.03.017_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jgar.2018.10.021","article-title":"Staphylococcus aureus at an Indian tertiary hospital: antimicrobial susceptibility and minimum inhibitory concentration (MIC) creep of antimicrobial agents","volume":"17","author":"Khurana","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jiac.2022.03.017_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2017.06.017","article-title":"Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections\u2014a systematic review and meta-analysis","author":"Diaz","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2022.03.017_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10096-010-1140-7","article-title":"Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem?","volume":"30","author":"Kehrmann","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2022.03.017_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jgar.2017.04.007","article-title":"Evaluation of vancomycin MIC creep in Staphylococcus aureus","volume":"10","author":"Diaz","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jiac.2022.03.017_bib12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis","volume":"54","author":"Van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.03.017_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations","volume":"204","author":"Holmes","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiac.2022.03.017_bib14","series-title":"National action plan on antimicrobial resistance (AMR) 2016-2020","year":"2016"},{"key":"10.1016\/j.jiac.2022.03.017_bib15","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3390\/antibiotics10111293","article-title":"Outcomes and future prospect of Japan's national action plan on antimicrobial resistance (2016\u20132020)","volume":"10","author":"Gu","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.jiac.2022.03.017_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2022.03.017_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3201\/eid0702.010237","article-title":"Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus","volume":"7","author":"Tenover","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2022.03.017_bib18","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2022.03.017_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2334-10-159","article-title":"Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg\/L, by the broth microdilution method","volume":"10","author":"Wang","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2022.03.017_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.03.017_bib21","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2022.03.017_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1128\/JCM.05520-11","article-title":"Is vancomycin MIC \u2018creep\u2019 method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010","volume":"50","author":"Edwards","year":"2012","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:04:04Z","timestamp":1761159844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1341321X22000964"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.03.017","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vancomycin MIC creep progresses in methicillin-resistant Staphylococcus aureus despite the national antimicrobial stewardship campaign: Single facility data in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}